Cargando…

Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach

Tumor necrosis factor-α (TNF-α) is a potent pro-inflammatory cytokine, involved in the pathogenesis and progression of immunoglobulin A nephropathy (IgAN). A bi-allelic polymorphism in the promoter region, at position -308 (G/A) of the TNF-α gene (rs1800629) is associated with an increased TNF-a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tziastoudi, Maria, Chronopoulou, Ioanna, Pissas, Georgios, Cholevas, Christos, Eleftheriadis, Theodoros, Stefanidis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378840/
https://www.ncbi.nlm.nih.gov/pubmed/37510392
http://dx.doi.org/10.3390/genes14071488
_version_ 1785079865879298048
author Tziastoudi, Maria
Chronopoulou, Ioanna
Pissas, Georgios
Cholevas, Christos
Eleftheriadis, Theodoros
Stefanidis, Ioannis
author_facet Tziastoudi, Maria
Chronopoulou, Ioanna
Pissas, Georgios
Cholevas, Christos
Eleftheriadis, Theodoros
Stefanidis, Ioannis
author_sort Tziastoudi, Maria
collection PubMed
description Tumor necrosis factor-α (TNF-α) is a potent pro-inflammatory cytokine, involved in the pathogenesis and progression of immunoglobulin A nephropathy (IgAN). A bi-allelic polymorphism in the promoter region, at position -308 (G/A) of the TNF-α gene (rs1800629) is associated with an increased TNF-a production. However, several previous association studies of TNF-α G-308A polymorphism and IgAN rendered contradictory findings. The objective of the present study is to shed light on these inconclusive results and clarify the role of TNF-α and any possible contribution of this factor in the development and progression of sporadic IgAN. Therefore, a meta-analysis of all available genetic association studies relating the TNF-α G-308A polymorphism to the risk for development and/or progression of IgAN was conducted. Seven studies were included in the meta-analysis. Three of them included populations of European descent (Caucasians) and four involved Asians. The generalized odds ratio (OR(G)) was used to estimate the risk for the development and/or progression of the disease. Overall, the meta-analysis did not detect any significant association between the G-308A variant and both the risk of developing IgAN and the risk for progression of IgAN. In conclusion, these results suggest that TNF-α does not constitute a key component in the genetic architecture of sporadic IgAN. However, further evidence deciphering the influence of TNF-α on IgAN is still needed.
format Online
Article
Text
id pubmed-10378840
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103788402023-07-29 Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach Tziastoudi, Maria Chronopoulou, Ioanna Pissas, Georgios Cholevas, Christos Eleftheriadis, Theodoros Stefanidis, Ioannis Genes (Basel) Article Tumor necrosis factor-α (TNF-α) is a potent pro-inflammatory cytokine, involved in the pathogenesis and progression of immunoglobulin A nephropathy (IgAN). A bi-allelic polymorphism in the promoter region, at position -308 (G/A) of the TNF-α gene (rs1800629) is associated with an increased TNF-a production. However, several previous association studies of TNF-α G-308A polymorphism and IgAN rendered contradictory findings. The objective of the present study is to shed light on these inconclusive results and clarify the role of TNF-α and any possible contribution of this factor in the development and progression of sporadic IgAN. Therefore, a meta-analysis of all available genetic association studies relating the TNF-α G-308A polymorphism to the risk for development and/or progression of IgAN was conducted. Seven studies were included in the meta-analysis. Three of them included populations of European descent (Caucasians) and four involved Asians. The generalized odds ratio (OR(G)) was used to estimate the risk for the development and/or progression of the disease. Overall, the meta-analysis did not detect any significant association between the G-308A variant and both the risk of developing IgAN and the risk for progression of IgAN. In conclusion, these results suggest that TNF-α does not constitute a key component in the genetic architecture of sporadic IgAN. However, further evidence deciphering the influence of TNF-α on IgAN is still needed. MDPI 2023-07-21 /pmc/articles/PMC10378840/ /pubmed/37510392 http://dx.doi.org/10.3390/genes14071488 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tziastoudi, Maria
Chronopoulou, Ioanna
Pissas, Georgios
Cholevas, Christos
Eleftheriadis, Theodoros
Stefanidis, Ioannis
Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach
title Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach
title_full Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach
title_fullStr Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach
title_full_unstemmed Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach
title_short Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach
title_sort tumor necrosis factor-α g-308a polymorphism and sporadic iga nephropathy: a meta-analysis using a genetic model-free approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378840/
https://www.ncbi.nlm.nih.gov/pubmed/37510392
http://dx.doi.org/10.3390/genes14071488
work_keys_str_mv AT tziastoudimaria tumornecrosisfactorag308apolymorphismandsporadiciganephropathyametaanalysisusingageneticmodelfreeapproach
AT chronopoulouioanna tumornecrosisfactorag308apolymorphismandsporadiciganephropathyametaanalysisusingageneticmodelfreeapproach
AT pissasgeorgios tumornecrosisfactorag308apolymorphismandsporadiciganephropathyametaanalysisusingageneticmodelfreeapproach
AT cholevaschristos tumornecrosisfactorag308apolymorphismandsporadiciganephropathyametaanalysisusingageneticmodelfreeapproach
AT eleftheriadistheodoros tumornecrosisfactorag308apolymorphismandsporadiciganephropathyametaanalysisusingageneticmodelfreeapproach
AT stefanidisioannis tumornecrosisfactorag308apolymorphismandsporadiciganephropathyametaanalysisusingageneticmodelfreeapproach